Legal Representation
Attorney
Peter T. Wakiyama
USPTO Deadlines
Application History
50 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 24, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Feb 24, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Jul 19, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 17, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 17, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jul 17, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Jan 22, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 18, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 18, 2019 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jan 18, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Jan 18, 2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jul 20, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 18, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jul 18, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 18, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Jul 18, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Feb 21, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Feb 20, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Feb 20, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Feb 5, 2018 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
Feb 5, 2018 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
Feb 5, 2018 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
Feb 5, 2018 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
Jan 18, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jul 18, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
May 23, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
May 23, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
May 3, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Apr 12, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 5, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Apr 5, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Apr 5, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Apr 5, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 5, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Apr 5, 2017 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Apr 5, 2017 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Apr 5, 2017 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Mar 27, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 27, 2017 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Mar 27, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Mar 16, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 15, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 15, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 15, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 15, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Sep 15, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Sep 8, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 2, 2016 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Jun 1, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
May 27, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Medical consulting services, namely, the retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; consulting services in the fields of health, medical care, pharmaceuticals and medicine; providing medical information in the fields of health, healthcare, life sciences, biotechnology, pharmaceuticals and pharmaceutical safety, bioinformatics, and genetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing medical information on drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the words "MOLECULAR HEALTH" above the larger words "MH INSIGHT", the "MH" being in stylized lettering consisting of vertical shapes.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"MOLECULAR HEALTH"